Skip to main content

Table 3 Risk of bias in the study included (King et al. [26])

From: Screening for sickle cell disease in newborns: a systematic review

Study

Both treatment groups studied in parallel (yes/no)

Comparability of groups or adequate control for confounding factors

Blinding patient/investigator

Selective reporting improbable

Absence of other factors potentially causing bias

Risk of bias (study level)

King et al. [26]

No

Uncleara

No/no

Yes

Yes

High

  1. aNo control for potential confounding factors. No baseline data available. Comparability of groups in terms of baseline characteristics seems likely, as newborns of the same region were included in both groups